Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT)
$149.26 USD
Updated Jul 19 12:00am
Add SRPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
SRPT News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesSarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.
SRPT Stock Chart More Charts
SRPT Price/Volume Stats
| Current price | $149.26 |
| Prev. close | $151.63 |
| Day low | $146.33 |
| Day high | $152.09 |
| 50-day MA | $131.09 |
| 200-day MA | $126.81 |
| 52-week high | $165.87 |
| 52-week low | $95.21 |
| Volume | 1,274,900 |
| Avg. volume | 1,237,059 |
| Dividend yield | N/A |
| Market Cap | 11.07B |
SRPT Returns
| 1-mo | 14.65% |
| 3-mo | 27.97% |
| 6-mo | 21.55% |
| 1-year | 11.96% |
| 3-year | 564.56% |
| 5-year | 591.98% |
| YTD | 36.77% |
| 2018 | 96.14% |
| 2017 | 102.84% |
| 2016 | -28.90% |
| 2015 | 166.62% |
| 2014 | -28.96% |
Loading social stream, please wait...